Cargando empresa
Just reported
Q3 2026 results
From Align Technology's results release of 28 de octubre de 2026; its quarterly report has since been filed.
Revenue
Actual
1,01B US$
+1,9 % y/y
-3,9 % q/qGuided
1,01B US$
midpoint
Within guide+0,5 %EPS, GAAP
Actual
1,90 US$
+144 % y/y
+26 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
169,2M US$
+76 % y/y
+9,8 % q/qGuided
—
No guide given
Company outlook
Q4 2026
- Revenue1B US$ – 1,02B US$-3,6 % y/y First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Align Technology is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.153,8B US$A+
MDLNMedline Inc.51,9B US$A
ALCAlcon Inc.36,1B US$A
BLCOBausch & Lomb Corp7,5B US$A-
ATRCAtriCure, Inc.2,9B US$A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct 2026CAGraded C, now A
Estados financieros completos →
Construido a partir de los propios informes de Align Technology, Inc. ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.
